Overview
Carcinoma in situ of the upper respiratory tract refers to non-invasive malignant epithelial neoplasms confined to the mucosal layer without local invasion. This condition is particularly rare in pediatric populations, where specific chromosomal aberrations like t(15;19) may indicate a distinct and aggressive clinical entity 1.Diagnosis
Cytogenetic Analysis: Identification of chromosomal translocation t(15;19) can be diagnostic, especially in young patients 1.
Histopathology: Poorly differentiated carcinoma with vesicular nuclei, prominent nucleoli, and extensive necrosis; positive for cytokeratin markers 1.
Imaging: CT or MRI to assess tumor extent and involvement of adjacent structures 1.
Clinical Presentation: Rapidly growing masses, often in the epiglottis or nasopharynx, with potential for superior vena cava syndrome 1.Management
Surgical Resection: Primary treatment for localized disease, aiming for complete removal 1.
Radiation Therapy: Adjunctive treatment, particularly for aggressive cases with high risk of recurrence 1.
Chemotherapy: Limited evidence in pediatric cases; specific drug classes and doses not detailed in current abstracts 1.Special Populations
Pediatrics: Presence of t(15;19) suggests a distinct aggressive subtype with poor prognosis; management requires multidisciplinary approach 1.Key Recommendations
Perform cytogenetic analysis, specifically looking for t(15;19) translocation, in pediatric patients with upper respiratory tract carcinoma for prognostic and diagnostic clarity (Evidence: Expert opinion) 1.
Consider aggressive surgical resection followed by adjuvant radiation therapy for localized carcinoma in situ, especially in pediatric cases with aggressive features (Evidence: Moderate) 1.
Closely monitor pediatric patients with carcinoma in situ due to the rapid progression and high mortality risk associated with t(15;19) translocation (Evidence: Weak) 1.References
1 Vargas SO, French CA, Faul PN, Fletcher JA, Davis IJ, Dal Cin P et al.. Upper respiratory tract carcinoma with chromosomal translocation 15;19: evidence for a distinct disease entity of young patients with a rapidly fatal course. Cancer 2001. link92:5<1195::aid-cncr1438>3.0.co;2-3)